[Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
Ringa
V
V
Ined, 94276 Le Kremlin-Bicêtre, France; Inserm, U822, 94276 Le Kremlin-Bicêtre, France.
Fournier
A
A
D000367:Age Factors; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D002140:California / Q000453:epidemiology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage; D005060:Europe / Q000453:epidemiology; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D015994:Incidence; D008593:Menopause; D008875:Middle Aged; D017698:Postmenopause; D015995:Prevalence; D011372:Progestins / Q000008:administration & dosage; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004967:Estrogens; D000960:Hypolipidemic Agents; D011372:Progestins; D020845:Selective Estrogen Receptor Modulators